172 related articles for article (PubMed ID: 36407762)
1. Expression of alternative transcription factor 4 mRNAs and protein isoforms in the developing and adult rodent and human tissues.
Sirp A; Shubina A; Tuvikene J; Tamberg L; Kiir CS; Kranich L; Timmusk T
Front Mol Neurosci; 2022; 15():1033224. PubMed ID: 36407762
[TBL] [Abstract][Full Text] [Related]
2. Functional diversity of human basic helix-loop-helix transcription factor TCF4 isoforms generated by alternative 5' exon usage and splicing.
Sepp M; Kannike K; Eesmaa A; Urb M; Timmusk T
PLoS One; 2011; 6(7):e22138. PubMed ID: 21789225
[TBL] [Abstract][Full Text] [Related]
3. Functional consequences of TCF4 missense substitutions associated with Pitt-Hopkins syndrome, mild intellectual disability, and schizophrenia.
Sirp A; Roots K; Nurm K; Tuvikene J; Sepp M; Timmusk T
J Biol Chem; 2021 Dec; 297(6):101381. PubMed ID: 34748727
[TBL] [Abstract][Full Text] [Related]
4. Isoform-Specific Reduction of the Basic Helix-Loop-Helix Transcription Factor TCF4 Levels in Huntington's Disease.
Nurm K; Sepp M; Castany-Pladevall C; Creus-Muncunill J; Tuvikene J; Sirp A; Vihma H; Blake DJ; Perez-Navarro E; Timmusk T
eNeuro; 2021; 8(5):. PubMed ID: 34518368
[TBL] [Abstract][Full Text] [Related]
5. Disruption and deletion of the proximal part of TCF4 are associated with mild intellectual disability: About three new patients.
Masson J; Pons L; Busa T; Missirian C; Lines M; Tevissen H; Diguet F; Rollat-Farnier PA; Lesca G; Sanlaville D; Schluth-Bolard C
Eur J Med Genet; 2022 Apr; 65(4):104458. PubMed ID: 35189377
[TBL] [Abstract][Full Text] [Related]
6. The Intellectual Disability and Schizophrenia Associated Transcription Factor TCF4 Is Regulated by Neuronal Activity and Protein Kinase A.
Sepp M; Vihma H; Nurm K; Urb M; Page SC; Roots K; Hark A; Maher BJ; Pruunsild P; Timmusk T
J Neurosci; 2017 Oct; 37(43):10516-10527. PubMed ID: 28951451
[TBL] [Abstract][Full Text] [Related]
7. Region and Cell Type Distribution of TCF4 in the Postnatal Mouse Brain.
Kim H; Berens NC; Ochandarena NE; Philpot BD
Front Neuroanat; 2020; 14():42. PubMed ID: 32765228
[TBL] [Abstract][Full Text] [Related]
8. The basic helix-loop-helix transcription factor TCF4 impacts brain architecture as well as neuronal morphology and differentiation.
Schoof M; Hellwig M; Harrison L; Holdhof D; Lauffer MC; Niesen J; Virdi S; Indenbirken D; Schüller U
Eur J Neurosci; 2020 Jun; 51(11):2219-2235. PubMed ID: 31919899
[TBL] [Abstract][Full Text] [Related]
9. Partial deletion of TCF4 in three generation family with non-syndromic intellectual disability, without features of Pitt-Hopkins syndrome.
Kharbanda M; Kannike K; Lampe A; Berg J; Timmusk T; Sepp M
Eur J Med Genet; 2016 Jun; 59(6-7):310-4. PubMed ID: 27132474
[TBL] [Abstract][Full Text] [Related]
10. TCF4 (e2-2; ITF2): a schizophrenia-associated gene with pleiotropic effects on human disease.
Navarrete K; Pedroso I; De Jong S; Stefansson H; Steinberg S; Stefansson K; Ophoff RA; Schalkwyk LC; Collier DA
Am J Med Genet B Neuropsychiatr Genet; 2013 Jan; 162B(1):1-16. PubMed ID: 23129290
[TBL] [Abstract][Full Text] [Related]
11. Neurodevelopmental models of transcription factor 4 deficiency converge on a common ion channel as a potential therapeutic target for Pitt Hopkins syndrome.
Rannals MD; Page SC; Campbell MN; Gallo RA; Mayfield B; Maher BJ
Rare Dis; 2016; 4(1):e1220468. PubMed ID: 28032012
[TBL] [Abstract][Full Text] [Related]
12. The emerging roles of TCF4 in disease and development.
Forrest MP; Hill MJ; Quantock AJ; Martin-Rendon E; Blake DJ
Trends Mol Med; 2014 Jun; 20(6):322-31. PubMed ID: 24594265
[TBL] [Abstract][Full Text] [Related]
13. Impairment of different protein domains causes variable clinical presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4.
Bedeschi MF; Marangi G; Calvello MR; Ricciardi S; Leone FPC; Baccarin M; Guerneri S; Orteschi D; Murdolo M; Lattante S; Frangella S; Keena B; Harr MH; Zackai E; Zollino M
Eur J Med Genet; 2017 Nov; 60(11):565-571. PubMed ID: 28807867
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor 4 and its association with psychiatric disorders.
Teixeira JR; Szeto RA; Carvalho VMA; Muotri AR; Papes F
Transl Psychiatry; 2021 Jan; 11(1):19. PubMed ID: 33414364
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective.
Quednow BB; Brzózka MM; Rossner MJ
Cell Mol Life Sci; 2014 Aug; 71(15):2815-35. PubMed ID: 24413739
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the expression pattern of the schizophrenia-risk and intellectual disability gene TCF4 in the developing and adult brain suggests a role in development and plasticity of cortical and hippocampal neurons.
Jung M; Häberle BM; Tschaikowsky T; Wittmann MT; Balta EA; Stadler VC; Zweier C; Dörfler A; Gloeckner CJ; Lie DC
Mol Autism; 2018; 9():20. PubMed ID: 29588831
[TBL] [Abstract][Full Text] [Related]
17. TCF4, schizophrenia, and Pitt-Hopkins Syndrome.
Blake DJ; Forrest M; Chapman RM; Tinsley CL; O'Donovan MC; Owen MJ
Schizophr Bull; 2010 May; 36(3):443-7. PubMed ID: 20421335
[TBL] [Abstract][Full Text] [Related]
18. The Psychiatric Risk Gene Transcription Factor 4 (TCF4) Regulates Neurodevelopmental Pathways Associated With Schizophrenia, Autism, and Intellectual Disability.
Forrest MP; Hill MJ; Kavanagh DH; Tansey KE; Waite AJ; Blake DJ
Schizophr Bull; 2018 Aug; 44(5):1100-1110. PubMed ID: 29228394
[TBL] [Abstract][Full Text] [Related]
19. Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain.
Brzózka MM; Radyushkin K; Wichert SP; Ehrenreich H; Rossner MJ
Biol Psychiatry; 2010 Jul; 68(1):33-40. PubMed ID: 20434134
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for preferential binding of human TCF4 to DNA containing 5-carboxylcytosine.
Yang J; Horton JR; Li J; Huang Y; Zhang X; Blumenthal RM; Cheng X
Nucleic Acids Res; 2019 Sep; 47(16):8375-8387. PubMed ID: 31081034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
